TLR2 and Insulin resistance: Furthermore, CD163, a predictor of increased risk of developing T2D [157] and Toll-like Receptor 2 (TLR2), a receptor involved in insulin resistance, inflammation, and diabetes [158], were found to be also elevated in N363S carriers in the presence of Dex [156].